rs5181 — LRP8 Trp466Cys

LRP8 Trp466Cys — An ApoE Receptor Variant at the Lipid Uptake Interface

The LRP8 gene¹¹ LRP8 gene
encodes ApoER2, apolipoprotein E receptor 2, a member of the LDL receptor superfamily that binds apolipoprotein E-enriched lipoproteins and mediates their endocytosis into cells. While LRP8 is best known for its role in neuronal Reelin signaling, it is also prominently expressed in adipocytes and macrophages, where it participates in apoE-directed lipid trafficking — making variants in this gene of potential relevance to fat storage and cardiovascular risk.

The Trp466Cys variant (rs5181) replaces a conserved tryptophan residue in the ligand-binding domain of LRP8 with a cysteine. Tryptophan residues in LDL receptor family ligand-binding repeats typically participate in the hydrophobic core of beta-hairpin structures²² hydrophobic core of beta-hairpin structures
The beta-hairpin fold positions the acidic residues that coordinate calcium and create the ligand-docking surface, and their substitution with cysteine introduces a free thiol group that can disrupt disulfide bonding patterns, potentially altering receptor conformation and ligand-binding affinity.

Note: Population frequency data for this variant are not available in current major databases (gnomAD, 1000 Genomes), indicating it is rare or population-restricted. The clinical interpretation below is based on the known biology of the LRP8 ligand-binding domain and the functional consequences documented for other LRP8 missense variants. Direct evidence for the Trp466Cys change specifically is limited to its presence in sequencing datasets — no functional studies or large association studies have examined this specific variant.

The Mechanism

LRP8 (ApoER2) contains an N-terminal ligand-binding domain³³ N-terminal ligand-binding domain
Composed of cysteine-rich LDL receptor type A repeats that coordinate calcium ions to create the binding surface for apolipoprotein E-containing lipoproteins including beta-VLDL and HDL comprising multiple LDLa repeats. Tryptophan 466 (in the canonical 870-amino-acid isoform) sits within this domain. In adipocytes — where LRP8 is overexpressed approximately 14-fold relative to whole-body average expression — the receptor is thought to mediate apoE-dependent uptake of triglyceride-rich lipoproteins alongside the more extensively studied LRP1 and VLDL receptor.

In macrophages, ApoER2/LRP8 deficiency has been shown to enhance lipid accumulation and susceptibility to oxidized LDL-induced cell death⁴⁴ ApoER2/LRP8 deficiency has been shown to enhance lipid accumulation and susceptibility to oxidized LDL-induced cell death
Zhou L et al. Apolipoprotein E receptor-2 deficiency enhances macrophage susceptibility to lipid accumulation and cell death to augment atherosclerotic plaque progression and necrosis. Biochimica et Biophysica Acta, 2014. ApoER2 limits PPARγ expression in macrophages and promotes cholesterol efflux via ABCA1, favoring an anti-inflammatory, antiatherogenic macrophage phenotype. A missense variant that disrupts ligand-binding domain integrity could reduce ApoER2-mediated cholesterol efflux, increasing foam cell formation risk.

The Evidence

Direct evidence for rs5181 (Trp466Cys) is limited to its presence in the dbSNP database (build 157) and the Illumina genotyping platform — no functional studies or population association studies have examined this variant specifically.

The broader significance of LRP8 missense variants in fat and lipid metabolism is supported by work on the R952Q variant (rs5174)⁵⁵ R952Q variant (rs5174)
Shen GQ et al. An LRP8 variant is associated with familial and premature coronary artery disease and myocardial infarction. Am J Hum Genet, 2007, which encodes a different missense change in LRP8 and has been associated with premature coronary artery disease and elevated plasma triglycerides in independent cohorts. The R952Q variant acts by increasing p38 MAPK activation in response to oxidized LDL, amplifying macrophage inflammatory signaling.

LRP8 has also been associated with triglyceride levels⁶⁶ LRP8 has also been associated with triglyceride levels
Horne BD et al. Genetic variant R952Q in LRP8 is associated with increased plasma triglyceride levels in patients with early-onset CAD and MI. Lipids in Health and Disease, 2012, further implicating the receptor in lipid homeostasis beyond simple LDL clearance.

ApoER2 deficiency in mice with LDL receptor knockout⁷⁷ ApoER2 deficiency in mice with LDL receptor knockout
Zhou et al. 2014 resulted in accelerated atherosclerosis with more complex lesions, more foam cell necrosis, and defective macrophage Akt signaling — demonstrating that loss of ApoER2 function in the lipid-laden vascular environment has substantive metabolic and structural consequences.

Practical Implications

Given the rarity of this variant and the absence of direct clinical studies, specific dietary or supplement recommendations tied exclusively to the Trp466Cys change would exceed the available evidence. However, if this missense variant reduces LRP8 function in a manner analogous to deficiency models, the most evidence-consistent implication is a potential reduction in ApoER2-mediated apoE-lipid uptake and macrophage cholesterol efflux — biological events that link to elevated cardiovascular and metabolic risk.

Carriers of rare LRP8 missense variants may benefit from monitoring of cardiovascular risk biomarkers, particularly plasma triglycerides and LDL-C, and from dietary strategies that reduce the load on the ApoE-receptor system (limiting dietary saturated fat reduces apoB-containing lipoprotein production that must be cleared via this pathway).

Interactions

LRP8 interacts with the ApoE pathway, making APOE genotype (specifically ε2/ε3/ε4) a likely modifier of LRP8 variant effects. A study examining the LRP8 R952Q variant found additive effects with APOE ε4 genotype on apoE plasma levels and MI risk, suggesting that carrying both a LRP8 missense variant and the APOE ε4 allele could compound the impairment of apoE-directed lipid clearance. Related SNPs in LRP8 include rs5174 (R952Q, the best-studied missense variant), rs2297660 (associated with birth weight and schizophrenia susceptibility), and rs5177 (3' UTR variant associated with cardiovascular outcomes).